Management of Severe Graves’ Hyperthyroidism in Pregnancy Following Immune Reconstitution Therapy in Multiple Sclerosis

CONTEXT: Alemtuzumab (ALZ), a CD52 monoclonal antibody, is highly efficacious in multiple sclerosis; however, side effects are common. Autoimmune thyroid disease (Graves’ disease and Hashimoto thyroiditis) is a well-known complication of ALZ. Treatment of ALZ-induced Graves’ disease can be challengi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammerstad, Sara Salehi, Celius, Elisabeth G, Husby, Henrik, Sørensen, Ingvild M, Norheim, Ingrid E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122367/
https://www.ncbi.nlm.nih.gov/pubmed/34017934
http://dx.doi.org/10.1210/jendso/bvab044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122367/
https://www.ncbi.nlm.nih.gov/pubmed/34017934
http://dx.doi.org/10.1210/jendso/bvab044

Ejemplares similares